4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GeoVax Labs, Inc. (GOVX) operates in the Biotechnology industry and is headquartered in Smyrna, United States with about 19 employees. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-12-31, GOVX reported $2M in revenue and ($22M) in net income.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.
Interactive charts & full statements → Open the GOVX valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2M | $4M | $0M | $0M | — |
| Operating Income (EBIT) | ($22M) | ($25M) | ($27M) | ($14M) | — |
| Net Income | ($22M) | ($25M) | ($26M) | ($14M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $1M | $2M | — |
| Operating Income (EBIT) | ($5M) | ($4M) | ($6M) | ($5M) | ($5M) | — |
| Net Income | ($5M) | ($4M) | ($6M) | ($5M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $6M | $8M | $9M | $31M | — |
| Total Liabilities | $2M | $3M | $4M | $5M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GOVX viewer.
About TickerBase · Data methodology & sources